How Innoviva, Inc. stacks up

INVA · against 440 other Healthcare companies of similar size

Overall

93/ 100

Near the top of its peers.

Ranked #3 of 441 · scores higher than 100% of peers

Bars: peers in each 10-point band of the overall score

3 peers with an overall score of 90–100, including INVA · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#27 of 449Score 94 / 100 · beats 92%Growth#35 of 411Score 91 / 100 · beats 91%Profitability#31 of 442Score 93 / 100 · beats 92%Risk#24 of 453Lower relative risk · safety 94 · beats 95%

Ranking by overall score

Top 5 and the companies ranked around INVA

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Lakefront Biotherapeutics NVLKFT · US-listed	2.1B USD	96	96	99	93	0 / 2
1	Zealand Pharma A/SZEAL.CO · Europe	15.6B DKK (≈$2.3B)	96	96	99	96	0 / 2
3	Innoviva, Inc.INVA · US-listed	1.5B USD	93	94	91	93	0 / 2
4	PharmaResearch Co., Ltd.214450.KQ · South Korea	2.29T KRW (≈$1.6B)	88	83	90	96	0 / 2
5	Shenyang Xingqi Pharmaceutical Co.,Ltd.300573.SZ · China	12.3B CNY (≈$1.7B)	85	83	86	99	0 / 2
6	InnoCare Pharma Limited9969.HK · Hong Kong	19.7B HKD (≈$2.5B)	84	84	98	87	0 / 2
6	Nurix Therapeutics, Inc.NRIX · US-listed	2.7B USD	84	75	98	99	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…